Research Study

Integrated Biological Markers for the Prediction of Treatment Response in Depression
Principal Investigator 
Raymond Lam

Overview

Body Locations and Systems 
Depression
Disorders and Conditions 
Depression
Health Conditions 
Major Depressive Disorder
ClinicalTrials.gov# 
NCT01655706
Status 
Recruiting
Study Start/End 
Jan 1, 2014 to Dec 31, 2021
Locations 
UBC Hospital
Name/Title 
Cindy Woo, Research Coordinator
Phone 
604-822-7627
Email Address 
cindy.woo@ubc.ca
Purpose of Study 

This study is a pilot to assess feasibility of the protocol in patients and controls across six participating sites. The goal is to identify biological markers (biomarkers)that can be measured at baseline or early in treatment to predict treatment outcome in individual patients with Major Depressive Disorder (MDD). Biomarkers of interest will be clinical (using interview and self-report measures), molecular (from blood samples) and neurobiological (using neuroimaging and EEG).


 

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.